KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 54 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $22,356,000 | -35.0% | 821,594 | -26.9% | 0.57% | -40.4% |
Q1 2015 | $34,407,000 | +8.1% | 1,124,056 | +32.2% | 0.95% | +27.7% |
Q4 2014 | $31,828,000 | -19.1% | 850,337 | -24.5% | 0.74% | -18.0% |
Q3 2014 | $39,337,000 | +27.5% | 1,125,854 | +69.9% | 0.91% | +46.8% |
Q2 2014 | $30,855,000 | +222.6% | 662,842 | +114.1% | 0.62% | +256.6% |
Q1 2014 | $9,563,000 | -51.7% | 309,592 | -65.2% | 0.17% | -56.5% |
Q4 2013 | $19,785,000 | – | 889,520 | – | 0.40% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |